Disseminated intravascular coagulation: Old disease, new hope

British Medical Journal

Volumn 327, Issue 7421, 2003, Pages 974-977

  Toh, Cheng Hock ^a   Dennis, Michael ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; ENZYME PRECURSOR; HEPARIN; CYTOKINE; THROMBIN;

BLEEDING; BLOOD COMPONENT THERAPY; BRAIN HEMORRHAGE; CAUSE OF DEATH; CELL ACTIVATION; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG CONTRAINDICATION; EARLY DIAGNOSIS; ENDOTHELIUM CELL; EPIDEMIOLOGICAL DATA; HEMOSTASIS; HUMAN; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; REVIEW; SEPSIS; THROMBOCYTE TRANSFUSION; INFLAMMATION; METABOLISM; PHYSIOLOGY;

CYTOKINES; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; INFLAMMATION; PROGNOSIS; THROMBIN;

EID: 0142185079     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7421.974     Document Type: Review

References (25)

1. Dupuy M. Injections de matière cérébrale dans les veines. Gaz Med Paris 1834;2:524.
2. Bernard GR, Vincent AL, Laterre PF, LaRosa S, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
3. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-30.
4. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996;75:224-8.
5. Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF, Hop WCJ, Dekker I, Joosten KFM, et al. Age-related differences in outcome and seventy of DIC in children with septic shock and purpura. Thromb Haemost 1996;76:932-8.
6. Shimamura K, Oka K, Nakazawa M, Kojima M. Distribution patterns of microthrombi in disseminated intravascular coagulation. Arch Pathol Lab Med 1983;107:543-7.
7. Giles AR, Nesheim ME, Mann KG. Studies of factors V and VIII:C in an animal model of disseminated intravascular coagulation. J Clin Invest 1984;74:2219-25.
8. Gando S, Nanzaki S, Sasaki S, Kemmotsu O. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost 1998;79:1111-5.
9. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 1996;93:10212-6.
10. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001;167:2887-94.
11. Von dem Borne PAK, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995;86:3035-42.
12. Kalafatis M, Swords NA, Rand MD, Mann KG. Membrane-dependent reactions in blood coagulation: role of the vitamin K-dependent enzyme complexes. Biochim Biophys Acta 1994;1227:113-29.
13. Satta N, Toti F, Feugas O, Bohbot A, Dachary-Prigent J, Eschwege V, et al. Monocyte vesiculatton is a possible mechanism for dissemination of membrane associated procoagulant activities and adhesion molecules after stimulation with lipopolysaccharide. J Immunol 1994;153:3245-55.
14. Combes V, Simon AC, Grau GE. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93-102.
15. Toh CH, Samis J, Downey C, Walker J, Becker L, Bruffato N, et al. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a calcium dependant complex of C-reactive protein with very-low-denstty-lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002;100:2522-9.
16. Van der Poll T, Buller HR, ten Cate H. Activation of coagulation after administration of tumour necrosis factor to normal subjects. N Engl J Med 1990;322:1622-7.
17. Coughlin SR. Thrombin signalling and protease activated receptors. Nature 2000;407:258-64.
18. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765-77.
19. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet 1997;349:1912-3.
20. Liaw PCY, Ferrell G, Esmon CT. A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation. J Thromb Haemost 2003;1:662-70.
21. Feinstein DI. Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 1982;60:284-7.
22. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001;276:11199-203.
23. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. High-dose antithrombin III in severe sepsis: a randomised controlled trial. JAMA 2001;286:1869-78.
24. Smith OP, White B, Vaughan D, Rafferty M, Claffey L, Lyons B, et al. Use of protein C concentrate, heparin and haemofiltration in meningococcus-induced purpura fulminans. Lancet 1997;359:1590-3.
25. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345:408-16.